Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 2/20 | 0.64 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.64 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.64 |
| ▸ | HTR2C | P28335 | 2/20 | 0.64 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.64 |
| ▸ | DRD1 | P21728 | 10/20 | 0.50 |
| ▸ | TEAD1 | P28347 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1596633 | 1.00 | ADRA2A (0.64) | ADRA2AADRA2BADRA2CHTR2CSLC6A3 | |
| Bromide SCHEMBL1597115 | 0.99 | ADRA2A (0.65) | ADRA2AADRA2BADRA2CHTR2CSLC6A3 | |
| SCHEMBL1597645 | 0.92 | ADRA2A (0.67) | ADRA2AADRA2BADRA2CHTR2CSLC6A3 | |
| SCHEMBL1597473 | 0.92 | ADRA2A (0.67) | ADRA2AADRA2BADRA2CHTR2CSLC6A3 | |
| Hydrochloric Acid SCHEMBL1597993 | 0.91 | ADRA2A (0.66) | ADRA2AADRA2BADRA2CHTR2CSLC6A3 | |
| SCHEMBL1597586 | 0.91 | ADRA2A (0.66) | ADRA2AADRA2BADRA2CHTR2CSLC6A3 | |
| Hydrochloric Acid SCHEMBL1598529 | 0.91 | ADRA2A (0.66) | ADRA2AADRA2BADRA2CHTR2CSLC6A3 | |
| Hydrochloric Acid SCHEMBL1598427 | 0.90 | ADRA2A (0.64) | ADRA2AADRA2BADRA2CHTR2CSLC6A3 | |
| SCHEMBL1597249 | 0.90 | ADRA2A (0.67) | ADRA2AADRA2BADRA2CHTR2CSLC6A3 | |
| SCHEMBL1597448 | 0.90 | ADRA2A (0.61) | ADRA2AADRA2BADRA2CHTR2CSLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1749001-B1 | 3-PIPERIDINYLISOCHROMAN-5-OLS AS DOPAMINE AGONISTS | AVENTIS PHARMA INC (US) | 2010-03-03 | — | — | EP | claimed |